For this type of clinical investigation, it would be highly recommended to get a written statement from the FDA regarding the applicability of the investigational device exemption regulations (21 CFR 812). Even if you are correct that the device as used should not be considered as meeting the FDA’s definition of a medical device, most IRB’s would focus their attention on the device’s status as home-grown (not approved) and device’s use during open-heart surgery and find it to be significant risk (requires an IDE) or else require a formal FDA determination. A statement from the FDA either concurring with your view or else labeling the use as non-significant risk would remove the question from the IRB and would ensure a more efficient IRB review process.